Ep. 105: Andrew Hessel: Programming DNA and Engineering the Future of Life

About this episode

Andrew Hessel discusses the engineering of DNA and the future of biotechnology.

In this episode, he and Niklas explore how genome sequencing, DNA synthesis, and CRISPR are turning life into an engineering platform. From coding proteins and viruses to writing entire genomes, Andrew explains how biotech is moving from reading DNA to actively programming it. They discuss N-of-1 personalized therapies, biosecurity in an age of cheap DNA synthesis, and why open science could accelerate biotech innovation. The conversation also touches on cloning, embryo editing, and the long-term future of human enhancement. Topics include: · DNA as digital code · Genome writing and synthetic cells · CRISPR and programmable biology · Personalized genetic medicine · Biosecurity and engineered viruses · Open biotech vs. proprietary models · Cloning and human genome design A conversation for builders, founders, and technologists thinking about biology as the next software layer. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com

People in this episode

Host: Niklas

Guest: Andrew Hessel

Topics covered

• genome sequencing
• DNA synthesis
• CRISPR
• personalized therapies
• biosecurity
• open science
• human enhancement

Keywords

• DNA
• genome writing
• synthetic biology
• personalized medicine
• biosecurity
• cloning
• human genome design

Mentioned in this episode

Organizations: Infinita City, CRISPR

More episodes of Stranded Technologies Podcast

• Ep. 110: Tomas Pueyo & Trey Goff On The Next Silicon Valley Might Be A New Country · June 4, 2026 · 2h 27m
• Ep. 109: Jonathan Anomaly on The Future of Human Enhancement, Genetic Selection & Startup Societies · May 21, 2026 · 1h 22m
• Ep. 108: The Buck Inst. President, Eric Verdin, on Pathways to Life Extension Acceleration: Alternative Pathways and Radical Hopium vs. Scientific Realism · May 8, 2026 · 46 min
• Ep. 107: Sid Sijbrandij On Beating Cancer with First Principles, n = 1 Personalized Treatments and Special Access Regulatory Pathways · April 10, 2026 · 47 min
• Ep. 106: Yaron Brook: Capitalism, Ayn Rand, and the Moral Case for Freedom · March 18, 2026 · 1h 13m
• Ep. 104: Ruxandra Teslo: Clinical Trials, Drug Innovation, and the Bottleneck to Biotech Abundance · February 20, 2026 · 1h 3m